Interestingly, the combination of entinostat with immune checkpoint inhibitors resulted in prolonged survival and delayed tumor growth along with an increase of CD8+ T effector cells in tumor-bearing mice (73, 74). The gene discussed is CD8A; the disease is neoplasm.